Skip to main content
Premium Trial:

Request an Annual Quote

MDRNA Closes $1M Bridge Loan

Premium

MDRNA said last week that it has closed a $1 million bridge loan worth $1 million.

Under the terms of the loan, the company sold $1 million in promissory notes and issued warrants to certain accredited investors to purchase an aggregate of about 1.1 million of its shares at $1.02 per share.

"This bridge loan provides us with the flexibility to pursue partnering and financing options into the beginning of next year," MDRNA President and CEO Michael French said in a statement. "As we continue to execute on our business strategy, this ensures that we have sufficient resources to achieve our near-term objectives."

The loan will become due and payable on February 1, 2010, with interest calculated at 12 percent annually and payable on the due date, MDRNA said. The loan is to be secured against the assets of MDRNA and its subsidiaries.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.